A few things here:
1. You are right Cartman that there is a concern of further dilution.
Below is the change between 2018 and May 2020.
Registrant’s Common Stock as of date: May 11, 2020: 186,857,749
As of December 31, 2018 the total number of outstanding common shares was 174,427,854 and as of March 7, 2019 the total number was 174,427,854.
Not as drastic the last two years.
-----------------------------
As management had stated they went ahead with the University's recommendations and decided to not go live with the product until the kiln was completed. If their hypothesis is correct than the wait will be worth it.
Better said, if the technology works, the technology works.
A valuation of $1 per share (approximately $200 million). versus 20 cents, is a 5x fold on a 5-10% dilution above. Again, risk to reward.
--------------------------
Your point has merit. 2020 is where we need to see the final test plant built and testing to occur. I'm still bullish personally. Although it is an all or nothing scenario until we see long-term contracts.
----------------------------------------------------------
News 
Market Data 
Discover 
AI
